Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2008
07/17/2008US20080171754 Certain pyrazoline derivatives with kinase inhibitory activity
07/17/2008US20080171732 e.g. ethyl6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-5-cyano-2-methoxynicotinate; reversible and selective purinergic receptor antagonist; anticoagulant; cardiovascular diseases; platelet aggregation, thrombotic occlusion, myocardial infarction and unstable angina
07/17/2008US20080171692 Substituted amides
07/17/2008DE19618586B4 Monoazo-Dispersionsfarbstoffe Monoazo disperse dyes
07/17/2008CA2674647A1 Chemical compounds 637
07/17/2008CA2674644A1 Sulfonamide derivatives as chymase inhibitors
07/16/2008EP1944308A1 Process for production of ortho-metallized 1:3 complex of iridium with homoligand
07/16/2008EP1944304A1 Novel sustituted 1H-dihydropyrazoles, their preparation and use
07/16/2008EP1944289A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
07/16/2008EP1943233A2 Compounds and compositions for protein kinase inhbitors
07/16/2008EP1943213A2 Ppar modulating biaromatic compounds
07/16/2008EP1943209A1 A process for preparing beta-ketoester compounds
07/16/2008EP1942899A2 Mitotic kinesin inhibitors
07/16/2008EP1392655B1 Potassium channel openers
07/16/2008EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents
07/16/2008CN101223141A Certain substituted amides, method of making, and method of use thereof
07/16/2008CN101223130A Glutamate aggrecanase inhibitors
07/16/2008CN101220024A A set of anti-cancer compound restraining kinase
07/16/2008CN101219990A Method for distillation of front cut fraction of trichloropyridine sodium alcoholate
07/16/2008CN101219989A 2-phenylpyridine derivant with triphenylamine and carbazole as modification group and synthesizing method thereof
07/16/2008CN101219988A Synthesis of 4,4í»disubstituted-2,2í»-dipyridine
07/16/2008CN101219987A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same
07/16/2008CN100402525C Pyridine derivatives as fungicidal compounds
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/15/2008US7399878 Pharmaceutical compounds
07/15/2008US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
07/15/2008US7399788 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
07/15/2008US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease
07/15/2008US7399776 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage
07/15/2008US7399775 β-amyloid protein production/secretion inhibitor
07/15/2008US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists
07/15/2008US7399735 Perfluoropolyether additives
07/15/2008US7399505 Nematic or cholesteric or chiral-smectic; high absolute values of dielectric anisotropy combined with a favorable ratio of viscosity to clearing point; light- and UV-stable, and also thermally stable; high voltage holding ratio
07/15/2008US7399432 Charge transport compositions and electronic devices made with such compositions
07/15/2008US7399320 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride
07/10/2008WO2008083054A2 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure
07/10/2008WO2008082840A1 Pim kinase inhibitors as cancer chemotherapeutics
07/10/2008WO2008082701A1 Method of forming a dry quaternary ammonium salt mixture
07/10/2008WO2008082500A2 Process for the synthesis of 2,6-diaminopyridines from glutarimidines
07/10/2008WO2008082487A2 Novel jnk inhibitors
07/10/2008WO2008081814A1 Method for selective separation of trivalent and tetravalent actinoids from trivalent lanthanoide using hybrid donor-type extracting agent having functional group carrying active oxygen and nitrogen atoms
07/10/2008WO2008081017A1 New n-alkynylcarboxamide derivatives
07/10/2008WO2008080938A1 Use 2-substituted pyridines for cancer treatment
07/10/2008WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
07/10/2008WO2008061795A3 N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's
07/10/2008WO2008022046B1 Dicer substrate rna peptide conjugates and methods for rna therapeutics
07/10/2008US20080167474 Effective agents for trapping and indentifying free radical species and find use as efficient antioxidants in physicochemical and biological systems; treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine-mediated conditions
07/10/2008US20080167472 Tunable phenylacetylene hosts
07/10/2008US20080167378 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits
07/10/2008US20080167351 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine
07/10/2008US20080167331 Lowering intraocular pressure; glaucoma
07/10/2008US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders
07/10/2008US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof
07/10/2008US20080167306 Novel Heteroaryl Derivative
07/10/2008US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases
07/10/2008US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases
07/10/2008US20080167197 Mass labels
07/10/2008US20080166765 Fungal cell wall synthesis gene
07/10/2008US20080166593 Organic Electroluminescent Devices
07/10/2008US20080166299 Prevent accumulation of amyloid deposits
07/10/2008CA2672940A1 Novel jnk inhibitors
07/09/2008EP1942106A1 Therapeutic agents useful for treating pain
07/09/2008EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
07/09/2008EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury
07/09/2008EP1940821A2 Novel vanilloid receptor ligands and their use for producing medicaments
07/09/2008EP1940814A1 Piperazine derivatives as antimalarial agents
07/09/2008EP1940813A1 Heterocyclic amide derivatives useful as microbiocides
07/09/2008EP1940792A2 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-1 and/or pim-3
07/09/2008EP1940791A1 Organic compounds
07/09/2008EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c
07/09/2008EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
07/09/2008EP1812392B1 Process for preparation of isonicotinic acid derivatives
07/09/2008EP1789041B1 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
07/09/2008EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms
07/09/2008EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
07/09/2008EP1465863B1 Potassium channel modulators
07/09/2008EP1421068B1 A process of synthesis of a tricyclic ketone intermediate
07/09/2008EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
07/09/2008CN101218237A Oxime derivative and preparations thereof
07/09/2008CN101218206A Histamine H3 receptor antagonists
07/09/2008CN101216668A SBQ aqueous sensitizing powder and its industrial synthesis method
07/09/2008CN101215276A N,N'-substituted phenylpropylamino acid phenylpropylaminoalcohols esters derivatives and preparation method thereof
07/09/2008CN101215261A Method for synthesizing of 2-oxo-3-pyridine formic acid ester and derivatives thereof
07/09/2008CN101215260A Method for preparing benzoylpyridine derivatices and salt thereof
07/09/2008CN101215259A Pyridines derivatives, pharmacological receivable salt thereof, composition containing the said substances and use thereof
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400513C Phenylalanine enamide derivatives
07/09/2008CN100400512C Benzoic acid derivatives as modulators of PPAR alpha and gamma
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/08/2008US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases
07/08/2008US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/08/2008US7396840 Chemokine receptor binding heterocyclic compounds
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/08/2008CA2368775C Treatment of cardiovascular and related pathologies
07/03/2008WO2008079924A1 Immune response modifier compositions and methods
07/03/2008WO2008079600A1 Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
07/03/2008WO2008079371A1 Modulators of c3a receptor and methods of use thereof
07/03/2008WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008WO2008077897A1 New products for the treatment of the iron chlorosis